The fine chemical sector in Europe is witnessing a notable transformation, primarily fueled by the pharmaceutical industry ...

The U.S. leads the global plant-based API market, growing at a 4.2% CAGR, powered by biotech and agri-tech advances. With CRISPR and synthetic biology, the U.S. rapidly scales plant-derived APIs for ...

These facilities aim to produce key starting materials (KSM) and active pharmaceutical ingredients (API) domestically, ...

The active ingredient in IkT-001Pro ... Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing Abelson Tyrosine Kinase inhibitor therapeutics for ...

reinforces the best-in-class characteristics of our clinically validated anti-a-syn active immunotherapy for the treatment of ...

But Trump can have one or the other — not both. And if his incoming administration succeeds in enacting the tariffs he’s ...

including active pharmaceutical ingredients and pharmaceutical intermediates, amino acids, as well as a wide range of enzymes for use in diagnostics, and biopharmaceutical contract manufacturing and ...

Sea's novel synthetic molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the central nervous system, "the CNS"Two potent, selective, pre-clinical stage ...

Invizyne is redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals, such as ...

Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...

Protenx, the company’s flagship line of products, stimulates olfactory and taste receptors in the gut and elsewhere in the body, delivering similar physiological effects of active pharmaceutical ...

Speaking on Tuesday, Li expressed hopes of co-developing products with Indian companies for global markets, highlighting past ...